Share Buyback: A ₹1,100 crore drugmaker will be repurchasing its shares for the first time

Shares of Jagsonpal Pharmaceutical Ltd. are in focus on Tuesday, March 10, after the company said its board of directors is looking at considering and approval a buyback proposal.The board is set to meet on Thursday, March 12, 2026, to consider and approval the proposal for buyback of the fully-paid up equity shares of face value ₹2 each, the company informed the exchanges on Monday.

As per data available on the Bombay Stock Exchange (BSE), this will be the first instance that the company will approve a share buyback proposal, if it does.
Back in July 2004, Jagsonpal Pharma had issued bonus shares in the ratio of 3:1, which means shareholders had received three free shares for every one share they held as on the record date.In January 2025, the company also carried out a stock split, where it divided shares with a face value of ₹5 into shares of face value of ₹2.

The company last declared a final dividend of ₹2.5 in September 2025, prior to which it had declared dividends of ₹5 in September 2024 and August 2023, respectively. In 2021, it declared two dividends of ₹4 and ₹1 in October and September, each.

Shares of Jagsonpal Pharma ended the previous session 2.5% lower at ₹169.05 apiece. The stock has declined 8.4% in the past month, 31% in the last six months and 12.2% this year, so far.

Also Read: Dixon Tech shares in focus after getting approval for 74:26 LED module JV with HKC